Ö. MUTLU Et Al. , "Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach," Journal of Biomolecular Structure and Dynamics , vol.40, no.2, pp.918-930, 2022
MUTLU, Ö. Et Al. 2022. Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach. Journal of Biomolecular Structure and Dynamics , vol.40, no.2 , 918-930.
MUTLU, Ö., Ugurel, O. M., Sariyer, E., Ata, O., Inci, T. G., Ugurel, E., ... KOÇER, S.(2022). Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach. Journal of Biomolecular Structure and Dynamics , vol.40, no.2, 918-930.
MUTLU, ÖZAL Et Al. "Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach," Journal of Biomolecular Structure and Dynamics , vol.40, no.2, 918-930, 2022
MUTLU, ÖZAL Et Al. "Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach." Journal of Biomolecular Structure and Dynamics , vol.40, no.2, pp.918-930, 2022
MUTLU, Ö. Et Al. (2022) . "Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach." Journal of Biomolecular Structure and Dynamics , vol.40, no.2, pp.918-930.
@article{article, author={ÖZAL MUTLU Et Al. }, title={Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach}, journal={Journal of Biomolecular Structure and Dynamics}, year=2022, pages={918-930} }